The total number of records retrieved from this search are 40. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_1800	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationVirus expressing GFP protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1MOI	In-vitro result100% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1801	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationVirus expressing GFP protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1MOI	In-vitro result100% cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1802	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationVirus expressing GFP protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1MOI	In-vitro result90% cell survival after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1803	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationVirus expressing GFP protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1MOI	In-vitro result80% cell survival after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1804	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationVirus expressing GFP protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1MOI	In-vitro result90% cell survival after 120 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1805	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationVirus expressing GFP protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result98% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1806	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationVirus expressing GFP protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result80% cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1807	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationVirus expressing GFP protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result70% cell survival after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1808	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationVirus expressing GFP protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result60% cell survival after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1809	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationVirus expressing GFP protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result90% cell survival after 120 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1810	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationVirus expressing GFP protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result90% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1811	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationVirus expressing GFP protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result60% cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1812	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationVirus expressing GFP protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result60% cell survival after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1813	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationVirus expressing GFP protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result40% cell survival after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1814	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationVirus expressing GFP protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result50% cell survival after 120 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1815	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationVirus expressing GFP protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration50 MOI	In-vitro result80% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1816	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationVirus expressing GFP protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration50 MOI	In-vitro result30% cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1817	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationVirus expressing GFP protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration50 MOI	In-vitro result10% cell survival after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1818	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationVirus expressing GFP protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration50 MOI	In-vitro result10% cell survival after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1819	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationVirus expressing GFP protein	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration50 MOI	In-vitro result100% cell killing	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1820	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationvirus expressing SV5-F gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1MOI	In-vitro result100% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1821	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationvirus expressing SV5-F gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1MOI	In-vitro result90% cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1822	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationvirus expressing SV5-F gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1MOI	In-vitro result80% cell survival after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1823	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationvirus expressing SV5-F gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1MOI	In-vitro result80% cell survival after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1824	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationvirus expressing SV5-F gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1MOI	In-vitro result90% cell survival after 120 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1825	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationvirus expressing SV5-F gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result90% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1826	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationvirus expressing SV5-F gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result70% cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1827	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationvirus expressing SV5-F gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result60% cell survival after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1828	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationvirus expressing SV5-F gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result50% cell survival after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1829	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationvirus expressing SV5-F gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration5 MOI	In-vitro result50% cell survival after 120 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1830	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationvirus expressing SV5-F gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result80% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1831	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationvirus expressing SV5-F gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result60% cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1832	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationvirus expressing SV5-F gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result40% cell survival after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1833	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationvirus expressing SV5-F gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result20% cell survival after 96 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1834	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationvirus expressing SV5-F gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result10% cell survival after 120 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1835	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationvirus expressing SV5-F gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration50 MOI	In-vitro result60% cell survival after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1836	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationvirus expressing SV5-F gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration50 MOI	In-vitro result20% cell survival after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1837	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationvirus expressing SV5-F gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration50 MOI	In-vitro result10% cell survival after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1838	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationvirus expressing SV5-F gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration50 MOI	In-vitro result100% cell killing	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545
IDOV_1839	Virus nameVesicular stomatitis virus	Virus strainMutant	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationvirus expressing SV5-F gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineProstate cancer cell line	Cell lineTRAMP-C2	Concentration of cell line2.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration50 MOI	In-vitro result100% cell killing	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedVirus induce apoptosis in cancer cells	Immunogenic effectNA	Clinical trialNA	PMID20172545